ECS BOTANICS HOLDINGS LTD — Capital/Financing Update 2021

Oct 26, 2021

Market Announcement

==> picture [33 x 50] intentionally omitted <==

27 October 2021

==> picture [451 x 5] intentionally omitted <==

ECS Botanics Holdings Limited (ASX: ECS) – Trading Halt

Description

The securities of ECS Botanics Holdings Limited (‘ECS’) will be placed in trading halt at the request of ECS, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Friday, 29 October 2021 or when the announcement is released to the market.

Issued by

Raj Logarajah

Adviser, Listings Compliance (Perth)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

27 October 2021 ASX Limited

ASX ANNOUNCEMENT ECS Botanics Holdings Ltd (ASX:ECS)

27 October 2021

==> picture [90 x 87] intentionally omitted <==

Ms. Oma Murad

Australian Securities Exchange

Level 40, Central Park 152-158 St George's Terrace

Perth WA 6000

By email: tradinghaltsperth@asx.com.au

TRADING HALT: ECS BOTANICS HOLDINGS LTD

Dear Ms Murad,

ECS Botanics Holdings Ltd (ASX: ECS) (“ECS” or the “Company”) requests that its securities be placed in a trading halt as follows:

1. The trading halt has been requested pending the release of an announcement regarding a capital raising (the, “ Announcement ”);

2. The trading halt should be until the release of the Announcement by the Company, expected to be no later than market pre-open on Friday, 29 October 2021; and

3. The Company is not aware of any reason why the trading halt should not be granted.

About ECS Botanics Holdings Ltd

ECS Botanics Holdings Ltd is a leading medicinal cannabis and hemp business. The company owns farms and medicinal cannabis facilities in Tasmania and Victoria for the cultivation, processing, and manufacturing of medicinal cannabis. ECS manufactures to EU GMP standards and also has the necessary licences to cultivate and manufacture medicinal cannabis for the wholesale extract, final dose and premium dry flower market. ECS cultivates hemp for the wholesale market and its retail food and wellness brand, while having obtained all the necessary licences to grow, supply and manufacture. ECS’ core focus is scale and low-cost production, without compromising quality.

For further information, please contact: Alexander Keach, Managing Director info@ecs-botanics.com

Authorised on behalf of ECS by Alex Keach, Managing Director

==> picture [596 x 70] intentionally omitted <==